GE HealthCare Stock (NASDAQ: GEHC)
There is a significant amount of activity occurring at each of the businesses that use the General Electric name.
One of the most well-known and successful multinational corporations is General Electric (NYSE:GE), also known simply as GE. It possesses a diversified business portfolio that includes operations in the areas of aviation, healthcare, renewable energy, and finance. GE has a division known as GE Healthcare that focuses on supplying healthcare providers with medical technology as well as services related to that technology. In this piece, we will do an in-depth performance analysis of GE stock as well as GE Healthcare and examine those topics at length.
The performance of GE’s stock in recent years has been highly unpredictable. The corporation has gone through a major reorganization in order to concentrate on the businesses that are vital to its operations and lower the amount of debt it carries. The stock price of GE has been exhibiting an increasing trend so far in 2021. This can be attributed to the improved economic conditions as well as the company’s attempts to streamline its business processes. The earnings report for the company’s Q4 2020 quarter came in higher than the market anticipated, and the company’s management presented an upbeat prognosis for the future.
As a result of all the recent shifts, Wall Street has moved ratings, price targets, and analyst coverage all over the place. As more time passes, a more precise picture emerges of what financial experts believe the individual components of the once-powerful American business are currently worth.
BTIG analyst Ryan Zimmerman began covering GE HealthCare Technologies (NASDAQ:GEHC) on Monday. He assigned the company a Hold rating and did not provide a price target, which indicates that he anticipates the company’s shares to move in tandem with the market as a whole.
GE HealthCare Stock had been performing significantly better than that at the beginning. GE HealthCare was separated from General Electric (GE) at the beginning of 2023, and since then, the company’s shares have increased by around 38%.
GE Healthcare’s Performance in the Industry
GE Healthcare is a major leader in the healthcare industry, having a global presence in more than 160 countries. The company is headquartered in the United States. The medical imaging, diagnostic, and monitoring systems, in addition to the various healthcare information technology solutions, make up the company’s product portfolio. GE Healthcare’s business has been able to withstand the COVID-19 pandemic, and the company has continued to invest in research and development in order to produce innovative new products and services.
Despite the new rating of “lukewarm,” shares of GE HealthCare are now trading 0.3% higher at lunchtime on Monday. Both the S&P 500 (SPX +0.10%) and the Dow Jones Industrial Average (DJIA +0.30%) are currently showing a loss of 0.6%.
After that run, Zimmerman decided to take a hands-off approach to the stock for the time being. The market analyst stated in a study published on Monday that the company “needs to establish a track record before jumping in,” pointing out that after the recent run, share prices are comparable to those of other healthcare companies. Instead of covering industrial players, he focuses on medical device and diagnostic company news. And Zimmerman is drawing parallels between the valuation of GE HealthCare and that of other firms like Medtronic (MDT) and Abbott Laboratories. (ABT).
For example, the current price of GE HealthCare shares is approximately 18 times the company’s expected earnings for 2024. The current market value of Abbott and Medtronic, respectively, is around 22 times and 15 times. GE Healthcare fits neatly in the middle of those two companies.
According to FactSet, there are now a total of five analysts covering GE HealthCare stock; two of them have Buy ratings, while the other three have Hold ratings. The number of ratings should continue to increase. The stock of Medtronic is covered by 30 analysts, while the stock of Abbott is covered by 25 analysts.
About 58% of stocks included in the S&P 500 have to Buy ratings assigned to them on average. In addition, there are approximately 22 analysts that watch the typical stock.
Now that GE HealthCare has been sold off, the company’s analysts are focusing more of their attention on the company’s surviving operations in the power generation and aerospace industries. As investors become increasingly upbeat about the prospects for a rebound in the commercial aviation industry, their price estimates for GE stock continue to rise.
On Monday, Citi analyst Andrew Kaplowitz increased his price target for General Electric Company stock from $93 to $106. Due to the growth of the aerospace industry, he revised his earnings-per-share projections for the years 2024 and 2025, increasing them from $3.35 and $4.35 to $3.60 and $4.75, respectively.
He recommends purchasing GE stock. The average price objective for GE stock is approximately $100, and there are a total of 67% of analysts covering the company who have to Buy ratings. Although the percentage of analysts who have Buy recommendations has remained relatively constant, their price targets for GE shares have increased by around $25 following the spin-off of GE HealthCare.
During the noon trade, GE stock has seen a gain of 0.7%. The price of the share has increased by around 44% so far this year.
The spin has resulted in a perceived value being established. Since the end of 2022, Wall Street estimates that the aggregate market value of companies affiliated with GE has increased to approximately $150 billion, from an estimate of approximately $100 billion.
The next spin is scheduled to take place in the early years of 2024, and it will involve the power-generation companies of wind and natural gas owned by GE. This particular business is known as GE Vernova.
In conclusion, General Electric is a long-standing firm that boasts a diverse range of business interests, one of which is the healthcare industry. The company has demonstrated resiliency by taking action to streamline its processes and refocusing its attention on its core businesses, despite the fact that it is experiencing difficulties in several of its business units. Despite the COVID-19 epidemic, GE Healthcare, which is part of GE, continues to maintain its position as a global leader in the healthcare industry. GE Healthcare’s performance has remained robust. We have high hopes that this article has provided you with an in-depth analysis of GE’s stock performance as well as its standing in the healthcare industry.
Featured Image: Megapixl © Jetcityimage
